Imitation of phase I metabolism of anabolic steroids by titanium dioxide photocatalysis — ASN Events

Imitation of phase I metabolism of anabolic steroids by titanium dioxide photocatalysis (#188)

Miina Ruokolainen 1 , Minna Valkonen 1 , Tiina Sikanen 1 , Tapio Kotiaho 1 , Risto Kostiainen 1
  1. University of Helsinki, Helsinki, Finland

The most important pathways in phase I metabolism are enzyme-catalyzed oxidations. Therefore, various oxidation methods, such as metalloporphyrins, Fenton reaction, electrochemical reactions and titanium dioxide (TiO2) photocatalysis, have been studied as alternatives for in vitro phase I metabolism studies.1-3   The aim of this study was to further investigate the feasibility of TiO2 photocatalysis for imitation of phase I metabolism of anabolic steroids.

The photocatalytic reactions of testosterone, methyltestosterone, metandienone, nandrolone and stanozolol were carried out in liquid phase using TiO2 Degussa P25 particles and ultra violet light. The metabolism reactions were studied in vitro using human liver microsomes (HLM). The samples were analyzed with ultra high performance liquid chromatography electrospray quadrupole time-of-flight mass spectrometry in positive ion mode.

For all the steroids studied, the main reactions observed both in TiO2 photocatalysis and HLM incubations were dehydrogenation, hydroxylation or combination of these two. Several isomers of hydroxylation and hydroxylation+dehydrogenation products were formed in both systems. Based on the same mass, retention time and similarity of the product ion spectra, many of the products observed in HLM reactions were also formed in TiO2 photocatalytic reactions. However, products characteristic to either of the systems were also formed.

In conclusion, TiO2 photocatalysis is a rapid and simple method for imitation of phase I metabolism reactions. The main reactions were same in TiO2 photocatalysis and HLM reactions. However, the stereochemistry of the products might be different and the feasibility of photocatalytic reactions for simulation of drug metabolism needs to be further studied.

  1. Lohmann, W. and Karst, U, Anal. Bioanal. Chem. 2008, 391: 79–96
  2. Calza, P. et al. J. Pharm. Biomed. Anal. 2004, 35: 9–19
  3. Nissilä, T. et al. Lab Chip 2011, 11: 1470–1476